Long non-coding RNA MEG3 and its genetic variant rs941576 are associated with rheumatoid arthritis pathogenesis in Egyptian patients

Arch Physiol Biochem. 2022 Dec;128(6):1571-1578. doi: 10.1080/13813455.2020.1784951. Epub 2020 Jul 1.

Abstract

Background: Rheumatoid arthritis (RA) is a joint destructive disorder. This study aimed to assess lncRNA MEG3 expression and its variant rs941576 in Egyptian patients with RA.

Subjects and methods: 100 RA patients and 100 healthy individuals were enrolled in the study. Quantitative PCR was used for expression analysis and allelic discrimination technology for genotyping.

Results: LncRNA MEG3 was down-regulated in RA patients and negatively associated with RA clinical features and HIF-1α and VEGF serum levels. On the contrary, it was positively associated with BAX serum levels in RA patients. The major A allele of rs941576 variant was associated with RA patients (p = .0003). AA genotype showed a significant decrease in lncRNA MEG3 expression and BAX and increase in HIF-1α and VEGF.

Conclusions: Serum lncRNA MEG3 expression showed negative association with increased susceptibility to RA. MEG3 gene rs941576 (A/G) polymorphism was associated with increased severity of RA in the current population.

Keywords: Bcl-2–associated X (BAX); Rheumatoid arthritis (RA); hypoxia inducible factor-1α (HIF-1α ); long non-coding RNA Maternally expressed gene 3 (MEG3); vascular endothelial growth factor (VEGF).

MeSH terms

  • Arthritis, Rheumatoid*
  • Egypt
  • Humans
  • RNA, Long Noncoding* / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • bcl-2-Associated X Protein

Substances

  • RNA, Long Noncoding
  • Vascular Endothelial Growth Factor A
  • bcl-2-Associated X Protein